For the first quarter of 2024, the Company expects to report total revenue between $11.0 million and $12.0 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CVRX:
- CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results and Announces Nadim Yared Retirement Plans
- CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- CVRx price target raised to $32 from $21 at Lake Street
- Barostim’s label upgrade caps off successful 2023 for CVRx, says Craig-Hallum
- CVRx receives FDA approval for expanded labeling of Barostim